Latest news
Loading news…
Dova Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Durham, North Carolina, United States Founded 2016 101-250 employees For Profit
Dova Pharmaceuticals focused on acquiring, developing and commercializing drug candidates.
Dova Pharmaceuticals was acquired by Swedish Orphan Biovitrum in 2019 for $915M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
33
Ticker
DOVA
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- DOVA
- Exchange
- NASDAQ
- IPO date
- Jun 29, 2017
- Raised at IPO
- $75M
- Valuation at IPO
- $424M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 19
- Active products
- 9
Company Info
- Founded
- 2016
- Employees
- 101-250
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 10
- HQ
- Durham, North Carolina, United States
- Region
- Research Triangle, East Coast, Southern US
- Exit date
- Jun 29, 2017
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.7
- Trend (90d)
- 0
33
professional contacts at Dova Pharmaceuticals
Contact execs at Dova Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Dova Pharmaceuticals
Loading news…
FAQs about Dova Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.